UCP Biosciences

UCP Biosciences, Inc.—a leading supplier of In Vitro Diagnostics (IVD)—offers top notch Point of Care Testing (POCT) devices ranging from instant urine and saliva drug test devices (in the U.S. Market) to Infectious Disease, Women’s Health, Cardiac Markers, and Tumor Markers (in the International Market). It delivers POCT products to a wide range of public and private sector including distributors, employment agencies, hospitals, occupational health clinics, pain management officials, doctor’s offices, resellers and rehabilitation centers. UCP’s FDA approved and CLIA Waived tests come in a single panel or any combination of multiple drug tests configurations in Dip Card, Round, Mini, Flat and Key Cup formats including: Amphetamine (AMP), Barbiturates (BAR), Benzodiazepines (BZO), Buprenorphine (BUP), Cocaine (COC), Methamphetamine (MET), Methadone (MTD), Ecstasy (MDMA), Opiates (OPI), Oxycodone (OXY), Phencyclidine (PCP), Propoxyphene (PPX), Marijuana (THC) and Tricyclic Antidepressants (TCA) with six different adulteration tests—pH, Creatinine (Cr), Specific gravity (S.G.), Oxidants (PCC), Nitrite (NIT) and Glutaraldehyde (GLU).